LEAWOOD, Kan., Feb. 12, 2019 /PRNewswire/ -- Aratana
Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company
focused on the development and commercialization of innovative
therapeutics for dogs and cats, will host a live conference call on
Tuesday, March 12, 2019 at
4:30 p.m. ET to discuss financial
results from the fourth quarter and full year ended December 31, 2018.
Interested participants and investors may access the audio
webcast or use the conference call dial-in:
1 (866) 364-3820 (U.S.)
1 (855) 669-9657 (Canada)
1 (412) 902-4210 (International)
A replay of the fourth quarter and full year 2018 results
teleconference will be available within several hours of the event
and an audio webcast will be accessible for 90 days in the Aratana
Investor Room. For a replay of the call, use the below dial-in and
conference ID 10128673:
1 (877) 344-7529 (U.S.)
1 (855) 669-9658 (Canada)
1 (412) 317-0088 (International)
About Aratana Therapeutics
Aratana Therapeutics is a
pet therapeutics company focused on developing and commercializing
innovative therapeutics for dogs and cats. As a pioneer in pet
therapeutics, Aratana's mission is to deliver safe and effective
therapeutics that elevate the standard of care in veterinary
medicine. We work with companion animal veterinarians to bring new
therapeutics to market that support the needs of pets and their
owners. For more information, please visit www.aratana.com.
Contacts
For investor inquires:
ir@aratana.com
(913) 353-1026
For media inquiries:
Rachel Reiff
media@aratana.com
(913) 353-1050
View original content to download
multimedia:http://www.prnewswire.com/news-releases/aratana-therapeutics-to-report-fourth-quarter-and-full-year-2018-financial-results-300794037.html
SOURCE Aratana Therapeutics, Inc.